Catalyst Wire Dossier Catalyst Wire Dossier

XEN45 Glaucoma Treatment System

· AbbVie
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XEN45 Glaucoma Treatment System, covering 2023-05-17 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China [Phase 4]

See pricing